GT200100106A - CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR. - Google Patents

CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR.

Info

Publication number
GT200100106A
GT200100106A GT200100106A GT200100106A GT200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A
Authority
GT
Guatemala
Prior art keywords
carboxialquileter
acat inhibitor
combinations
arteroscleroisis
aciltransferiaid
Prior art date
Application number
GT200100106A
Other languages
Spanish (es)
Inventor
Bruce Jeffrey Auerbach
Donna Lee Zobel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200100106A publication Critical patent/GT200100106A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN CARBOXIALQUILETER QUE REDUCE TRIGLICERIDOS Y LDL Y ELEVA HDL Y UN INHIBIDOR DE ACAT O MEJOR CONOCIDO COMO ACILCOENZIMA A : COLESTEROL ACILTRANSFERASA, QUE MEJORA LA DISLIPIDEMIA EN MAMIFEROS, DICHA COMPOSICION ES UTIL PARA TRATAR LA DISPLIPIDEMIA Y SINDROMES ISQUEMICOS Y PARA PREVENIR O RETARDAR EL COMIENZO DE ATAQUES CARDIACOS, ADEMAS SIRVE PARA TRATAR LA HIPERCOLESTEROLEMIA Y LA ARTEROSCLEROISIS.THE INVENTION CONCERNS A PHARMACEUTICAL COMPOSITION THAT INCLUDES A CARBOXIALQUILETER THAT REDUCES TRIGLICERIDES AND LDL AND ELEVATES HDL AND A ACAT INHIBITOR OR BETTER KNOWN AS ACILCOENZIMA A: COLESTEROL ACILTRANSFERIAID LABELS THEMSELVES, COMPOSED TO THREE AND ISCHEMICAL SYNDROMES AND TO PREVENT OR DELAY THE BEGINNING OF CARDIAC ATTACKS, WE ALSO SERVE TO TREAT HYPERCHOLESTEROLEMIA AND ARTEROSCLEROISIS.

GT200100106A 2000-06-07 2001-06-05 CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR. GT200100106A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21005600P 2000-06-07 2000-06-07

Publications (1)

Publication Number Publication Date
GT200100106A true GT200100106A (en) 2002-05-20

Family

ID=22781424

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200100106A GT200100106A (en) 2000-06-07 2001-06-05 CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR.

Country Status (14)

Country Link
EP (1) EP1292363A2 (en)
JP (1) JP2003535125A (en)
AR (1) AR034255A1 (en)
AU (1) AU2001263003A1 (en)
BR (1) BR0111428A (en)
CA (1) CA2413906A1 (en)
GT (1) GT200100106A (en)
MX (1) MXPA02010762A (en)
PA (1) PA8518601A1 (en)
PE (1) PE20020265A1 (en)
SV (1) SV2002000466A (en)
TN (1) TNSN01085A1 (en)
UY (1) UY26752A1 (en)
WO (1) WO2001093845A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387236B2 (en) 2001-10-09 2008-06-17 Delaware Capital Formation, Inc. Dispensing of currency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311356C (en) * 1998-01-28 2004-07-13 Warner-Lambert Company Method for treating alzheimer's disease

Also Published As

Publication number Publication date
JP2003535125A (en) 2003-11-25
TNSN01085A1 (en) 2005-11-10
EP1292363A2 (en) 2003-03-19
BR0111428A (en) 2003-06-10
PA8518601A1 (en) 2002-07-30
MXPA02010762A (en) 2003-03-10
CA2413906A1 (en) 2001-12-13
WO2001093845A3 (en) 2002-10-10
AU2001263003A1 (en) 2001-12-17
AR034255A1 (en) 2004-02-18
SV2002000466A (en) 2002-04-03
PE20020265A1 (en) 2002-04-19
WO2001093845A2 (en) 2001-12-13
UY26752A1 (en) 2001-07-31

Similar Documents

Publication Publication Date Title
UY26929A1 (en) ANTIANGIOGEN POLIPEPTIDES AND METHODS TO INHIBIT THE ANGIOGENESIS
GT200500137A (en) USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS.
PA8506101A1 (en) USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION
GT200000158A (en) PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY.
GT200300053A (en) COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR
UY26883A1 (en) THERAPEUTIC COMBINATION
AR022023A1 (en) COMBINATIONS OF ILEO-BILIAR ACID TRANSPORTATION INHIBITORS WITH FIBRIC ACID DERIVATIVES FOR CARDIOVASCULAR PRESCRIPTIONS
CU23213A3 (en) DIFENILUREAS REPLACED WITH OMEGA-CARBOXIARILO AS RAF QUINASA INHIBITORS
GT200300054A (en) COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR
EA200300953A1 (en) THERAPEUTIC COMBINATIONS FOR USE IN CARDIOVASCULAR AND INFLAMMATORY DISEASES
BRPI0520669A2 (en) pharmaceutical dosage that reduces the effect of food found for atorvastatin administration
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
PA8513601A1 (en) PHARMACEUTICAL COMPOSITIONS OF GLUCOGENOPHOSPHORILASE INHIBITORS
GT200000077A (en) MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA
MX2008001597A (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment.
BR0213181A (en) Cox-2 inhibitor combinations
ECSP003707A (en) DIAZEPANES
PA8464601A1 (en) COMBINATIONS OF STATIN-CARBOXYALKYL ETHER
AR054368A1 (en) METHOD TO TREAT HYPERLIPIDEMIA
GT200100106A (en) CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR.
SV2004000109A (en) COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES REF.LEA 33846-SV
MA44513B1 (en) Physiologically balanced injectable formulations of fosnetupitant
PA8469001A1 (en) MMP STATIN-INHIBITOR COMBINATIONS.
DOP2001000150A (en) HYPERTENSIVE AGENT AND ITS USE
SV2002000639A (en) PHENOXYPHENYL ALCANOSULFONATES REF. READ 34813-SV